Candriam SCA’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-373,706
Closed -$3.18M 922
2021
Q2
$3.18M Buy
373,706
+373,681
+1,494,724% +$3.83M 0.02% 492
2021
Q1
$0 Buy
+25
New +$406 ﹤0.01% 822

Other funds holding BCEL

Candriam SCA's BCEL Position: Q3 2021 in Review

Candriam SCA sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q3 2021, closing a stake of 373,706 shares — an estimated $3.18M sold.

Candriam SCA first reported a position in BCEL in Q1 2021 and held it in 2 quarters. The position peaked at $3.18M in Q2 2021. 107 funds tracked by Wall St. Rank hold BCEL as of Q3 2021.

  • Candriam SCA reported no remaining Atreca, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
  • Candriam SCA sold 373,706 Atreca, Inc. Class A Common Stock shares in Q3 2021, an estimated $3.18M.
  • Candriam SCA first reported a position in Atreca, Inc. Class A Common Stock in Q1 2021 and held it in 2 quarters.
  • Candriam SCA's Atreca, Inc. Class A Common Stock position peaked at $3.18M in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q3 2021.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.